SUNA 2008 - Darifenacin's Effectiveness in OAB Wet Patients as Measured by Dry Days - Highlight
PHILADELPHIA, PA, USA (UroToday.com) - This analysis set forth to determine the onset and number of consecutive dry days and reductions of UI episodes (IEs) provided by darifenacin, using pooled data from 3 phase III studies (multicenter, randomized, double-blind, placebo-controlled 12-week studies with darifenacin of fixed-doses of 7.5 and 15 mg once daily).
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
